B.C. government won't fund drug for rare disease for nine-year-old girl
VICTORIA – The British Columbia government says it will no longer fund an expensive drug for a nine-year-old girl who has a rare and terminal condition.
Health Minister Josie Osborne says in a statement that Charleigh Pollock's condition with Batten Disease has reached the point where she meets the criteria to discontinue the use of Brineura.
The girl has been receiving the drug therapy since 2019 at a cost of about $1 million a year.
She is the only person in the province, and one of 13 children in Canada, who has the genetic and fatal disorder that results in multiple seizures a day.
The statement says clinical evidence shows that once a patient has declined in motor skills and language functions by a certain amount, the drug is no longer a benefit in slowing the progression of the disease.
Wednesdays
Columnist Jen Zoratti looks at what's next in arts, life and pop culture.
Osborne says a Canada Drug Agency review of the latest research on the girl's disease found there was no evidence to support its continuing drug coverage, given the advanced stage of her condition.
This report by The Canadian Press was first published June 18, 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
Canadian Food Inspection Agency finds rare disease at B.C. commercial pigeon premises
CHILLIWACK – Canada's food inspection agency says it has uncovered a case of Newcastle disease at a commercial pigeon operation in Chilliwack, B.C., requiring the birds to be culled and the premises to be disinfected. The Canadian Food Inspection Agency says the virus affects both wild and domestic birds and can cause pink eye in humans. It says the ailment is of great concern to the world's agricultural community since it's highly contagious and threatens poultry. The agency says mild strains affect domestic poultry and pigeons and more severe strains can kill chickens. It says Newcastle disease can decrease egg production in domestic birds and cause high numbers of sudden deaths in a flock, while wild birds can develop wing paralysis and be left unable to fly. It says the risk to humans is low if gloves are worn while handling infected birds, and that the disease was rarely found to kill wild birds before 1990. This report by The Canadian Press was first published June 18, 2025.
Global News
3 hours ago
- Global News
As B.C.'s over-50 population grows, advocates want the shingles vaccine covered
Seniors' advocates are calling on the province to pay for the shingles vaccine. Currently, the shingles vaccine is not covered under B.C. MSP but it is funded in some other provinces for certain age groups. The vaccine is recommended for adults aged 50 and older and according to studies is more than 90 per cent effective. Almost 40 per cent of B.C.'s population is over 50 and physicians warn that shingles, which is a debilitating condition itself, can lead to other, more serious health concerns. Victoria-based physician, Dr. Wayne Ghesquiere, said any barriers to vaccination should be removed. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy 'Removing any obstacle to getting the vaccine, sometimes cost is an obstacle, the number-one obstacle is actually a health-care provider recommending the vaccine and educating the public what are the risks of shingles and the benefits of it,' he said. Story continues below advertisement 'That's the number-one obstacle. Patients just aren't aware of the risks that they have.' 1:53 N.S. to cover cost of shingles vaccine for residents 65 and older starting end of May Two doses of the vaccine are usually required and in B.C., the cost is approximately $150 per dose. B.C. Health Minister Josie Osborne said they are always open to discussions about what should be funded by the government. 'I think that's an excellent question in terms of the impact shingles as a disease can have on people and their health,' she said. Seniors' advocates would like to see the vaccine covered under MSP. 'The only thing standing in the way of British Columbia providing it is having the political will to do so,' Laura Tamblyn Watts, founder and CEO of CanAge said. Story continues below advertisement 'And making sure that we are standing up for science.'
CTV News
4 hours ago
- CTV News
B.C. not funding costly treatments for 9-year-old with rare disease
Charleigh Pollock poses on a field trip with her classmates on June 13, 2025. A Vancouver Island family is heartbroken after learning the B.C. government won't continue funding a vital drug treatment for Charleigh Pollock that her parents says is keeping her alive. Health Minister Josie Osborne announced the province's decision Wednesday afternoon. 'There is no evidence to support changing the discontinuation criteria, or to support the ministry continuing to provide coverage for Brineura given the advanced condition and stage of Charleigh's condition,' Osborne said. Brennan Day, the B.C. Conservatives' critic for rural health and seniors health, pounced on the decision. 'The health care authority should be ashamed,' said Day. Charleigh suffers from Batten disease, a rare neurodegenerative disorder that leads to the progressive loss of brain function and will ultimately lead to her death. Related: B.C. to cut off drug treatment for 9-year-old girl with rare disease She was diagnosed at the tender age of three after Charleigh began suffering from relentless seizures. She was put on the drug Brineura, which slowed the progression of the disease and stopped the seizures completely. 'Their journey, like all families that have a child diagnosed with a rare illness, is one that is filled with uncertainty, fear and endless advocacy,' said Osborne. In February, the province informed Charleigh's medical team that she would no longer be covered for the expensive drug, which costs $844,000 per year. The young girl's medical team then appealed that decision, and the health minister stepped in and extended those treatments while the appeal process was ongoing. CTV News spoke with Jori Fales, Charleigh's mother, last week after being notified by the government that a decision would be coming out before June 19. 'It's my last mother's plea,' said Fales. 'This is a crucial decision that affects my daughter's life and our family, and I just want them to make the right decision.' Fales understandably was not available for comment Wednesday. B.C.'s Expensive Drug For Rare Disease Committee was tasked with making the decision that ultimately found Charleigh no longer met the criteria for the drug coverage. During that process, the committee asked the Canada Drug Agency to do an evidence-based review of Brineura. The findings in that report gave Fales hope that the decision would go in Charleigh's favour. 'Insufficient data to establish discontinued criteria,' said Fales last week while reading quotes from the report. 'Without the appropriate data to help inform stopping the drug, continuation should truly be a clinical decision made with the health care team and the families involved.' The critic for rural health said he understands that tough decisions have to be made, but question the way the province went about that appeals process, not communicating with the family for months. 'The up and down decision making and the lack of transparency from the health authority around this is truly appalling,' said Day. Thursday will be Charleigh's final Brineura infusion. After that she will no longer have access to the life-preserving drug. 'Brineura is the only defence against this horrible disease, so if you take it away she will decline, lose more skills and leave us,' said Fales.
